1. Zhang, Axin, Guo, Xuefei, Bao, Kaikai, Gao, Zexia, Wang, Huanling. 2024. Molecular Characterization and Expression Changes of the bcl2l13 Gene in Response to Hypoxia in Megalobrama amblycephala. In Current issues in molecular biology, 46, 1136-1149. doi:10.3390/cimb46020072. https://pubmed.ncbi.nlm.nih.gov/38392190/
2. Lim, Jung Hwa, Kang, Hyun Mi, Kim, Dae Hun, Kim, Nam-Soon, Jung, Cho-Rok. 2023. ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model. In The Journal of experimental medicine, 221, . doi:10.1084/jem.20230367. https://pubmed.ncbi.nlm.nih.gov/37934410/
3. Ju, Liping, Chen, Shuqin, Alimujiang, Miriayi, Yang, Ying, Jia, Weiping. 2018. A novel role for Bcl2l13 in promoting beige adipocyte biogenesis. In Biochemical and biophysical research communications, 506, 485-491. doi:10.1016/j.bbrc.2018.10.034. https://pubmed.ncbi.nlm.nih.gov/30352689/
4. Jensen, Samuel A, Calvert, Andrea E, Volpert, Giora, Futerman, Anthony H, Stegh, Alexander H. 2014. Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. In Proceedings of the National Academy of Sciences of the United States of America, 111, 5682-7. doi:10.1073/pnas.1316700111. https://pubmed.ncbi.nlm.nih.gov/24706805/
5. Meng, Fei, Zhang, Luojin, Zhang, Mingjun, Xiao, Jun, Dai, Haiming. 2021. Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma. In Cancer cell international, 21, 332. doi:10.1186/s12935-021-02039-y. https://pubmed.ncbi.nlm.nih.gov/34193180/
智鼠故事 
